BTIG reiterates Buy rating on Carlsmed, $23 price target

BTIG reiterated their Buy rating on Carlsmed's stock with a price target of $23.00.The price target implies an upside of 52.3% from the Sep 25 close of $15.10.Key takeaways from the analyst noteStrong Growth Trajectory: Carlsmed is experiencing impressive revenue growth, with a projected compound a…